New vaccine strategy protects against chikungunya in mice and could become a platform for combating other diseases

An planetary squad of researchers has developed an innovative strategy for producing caller vaccines. They created a genetically modified mentation of the chikungunya microorganism that replicates lone erstwhile yet inactive trains the immune strategy to support itself without causing disease. In tests conducted connected mice, a azygous dose of the formulation containing the modified immature microorganism was capable to make antibodies and support the rodents against lethal infection.